These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 22690659)

  • 1. Blood cells show differences in DNA methylation in schizophrenia patients.
    Wilkinson J
    Epigenomics; 2012 Jun; 4(3):247-8. PubMed ID: 22690659
    [No Abstract]   [Full Text] [Related]  

  • 2. Epigenetic aberrations in leukocytes of patients with schizophrenia: association of global DNA methylation with antipsychotic drug treatment and disease onset.
    Melas PA; Rogdaki M; Ösby U; Schalling M; Lavebratt C; Ekström TJ
    FASEB J; 2012 Jun; 26(6):2712-8. PubMed ID: 22426120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verification of proposed peripheral biomarkers in mononuclear cells of individuals with schizophrenia.
    Yao Y; Schröder J; Karlsson H
    J Psychiatr Res; 2008 Jul; 42(8):639-43. PubMed ID: 17825842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired glycolytic response in peripheral blood mononuclear cells of first-onset antipsychotic-naive schizophrenia patients.
    Herberth M; Koethe D; Cheng TM; Krzyszton ND; Schoeffmann S; Guest PC; Rahmoune H; Harris LW; Kranaster L; Leweke FM; Bahn S
    Mol Psychiatry; 2011 Aug; 16(8):848-59. PubMed ID: 20585325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longterm maintenance therapy with depot haloperidol in schizophrenia.
    Zbytovský J
    Homeost Health Dis; 1991; 33(5-6):287. PubMed ID: 18265499
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No association between global leukocyte DNA methylation and homocysteine levels in schizophrenia patients.
    Bromberg A; Levine J; Nemetz B; Belmaker RH; Agam G
    Schizophr Res; 2008 Apr; 101(1-3):50-7. PubMed ID: 18276118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of schizophrenia with long-acting fluphenazine, haloperidol, or risperidone.
    Olfson M; Marcus SC; Ascher-Svanum H
    Schizophr Bull; 2007 Nov; 33(6):1379-87. PubMed ID: 17470444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An importance of dose in antipsychotic combination therapy for schizophrenia.
    Suzuki T
    J Clin Psychopharmacol; 2011 Jun; 31(3):399; author reply 399-400. PubMed ID: 21532376
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of optimal doses of a neuroleptic: preliminary results.
    Potkin SG; Urbanchek MS; Kirch DG; Bunney WE
    Clin Neuropharmacol; 1986; 9 Suppl 4():437-9. PubMed ID: 2882848
    [No Abstract]   [Full Text] [Related]  

  • 11. Genome-wide methylation analysis of treatment resistant schizophrenia.
    De Luca V; Chaudhary Z; Al-Chalabi N; Qian J; Borlido C; Gerretsen P; Graff A; Remington G; Chintoh A
    J Neural Transm (Vienna); 2023 Feb; 130(2):165-169. PubMed ID: 36648581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Back to the past in schizophrenia genomics.
    Sharp AJ; Akbarian S
    Nat Neurosci; 2016 Jan; 19(1):1-2. PubMed ID: 26713739
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter: Dosage of antipsychotic drugs.
    Ericksen SE; Hurt SW; Davis JM
    N Engl J Med; 1976 Jun; 294(23):1296-7. PubMed ID: 4732
    [No Abstract]   [Full Text] [Related]  

  • 14. Intramuscular haloperidol decanoate for neuroleptic maintenance therapy.
    arap Mengech HN; Wazome EG
    East Afr Med J; 1984 Jun; 61(6):435-8. PubMed ID: 6152736
    [No Abstract]   [Full Text] [Related]  

  • 15. Genome-wide expression analysis of peripheral blood identifies candidate biomarkers for schizophrenia.
    Kuzman MR; Medved V; Terzic J; Krainc D
    J Psychiatr Res; 2009 Sep; 43(13):1073-7. PubMed ID: 19358997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and economic approach to evaluation of the effectiveness of moditen-depot and haloperidol decanoate in the maintenance therapy of attack-like schizophrenia].
    Ushakov IuV; Kravchenko NE; Kopeĭko GI; Kalugina LI; Mirzoian MG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(7):99-104. PubMed ID: 1979463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide DNA methylation analysis in alcohol dependence.
    Zhang R; Miao Q; Wang C; Zhao R; Li W; Haile CN; Hao W; Zhang XY
    Addict Biol; 2013 Mar; 18(2):392-403. PubMed ID: 23387924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amisulpride: a review of its efficacy in schizophrenia.
    Möller HJ
    Acta Psychiatr Scand Suppl; 2000; 400():17-22. PubMed ID: 10823307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response relationship of sertindole and haloperidol using the pharmacopsychometric triangle.
    Bech P; Tanghøj P; Andreasson K; Overø KF
    Acta Psychiatr Scand; 2011 Feb; 123(2):154-61. PubMed ID: 20560900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comment on 'reduced haloperidol does not interfere with antipsychotic activity of halperidol in the treatment of acute schizophrenia'.
    Altamura AC; Bareggi SR
    Int Clin Psychopharmacol; 2000 Sep; 15(5):303-4. PubMed ID: 10993133
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.